U.S. Uterine Fibroid Market is expected to reach USD 39,993.2 million by 2022.

U.S. Uterine Fibroid Market is expected to reach USD 39,993.2 million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%.

Pune, India – June 29, 2017 /MarketersMedia/ —

Introduction:
Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman*s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fuelled the growth of this market.

Do Inquiry Before Purchasing Report Here: https://market.biz/report/u-s-uterine-fibroid-market-mrf/102064/#inquiry

U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others.The U.S. Market for Uterine Fibroids is expected to reach USD 39,993.2 million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%.

Key Finding
1) The U.S. Uterine Fibroid market and is expected to reach USD 39,993.2 million by 2022.
2) By Type, Intramural Fibroids holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 14,972.5 million by 2022.
3) By Treatment, hysterectomy holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 8,042.3 million by 2022.

Key Players for Uterine Fibroid Market:
Some of the key players in this market are: AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.), and others.

Target Audience
1) Uterine Fibroid Devices and Drug Manufacturers
2) Uterine Fibroid Devices and Drug Suppliers
3) Private Research Laboratories
4) Research and Development (R&D) Companies
5) Market Research and Consulting Service Providers
6) Medical Research Laboratories

About Market.Biz:
Market.Biz consists of a highly motivated team of young and experienced individuals who are detail-oriented and highly focused on providing clients with the information they need. Information is king in the business world, and we specialize in providing that.

Referal News Network: http://editiontime.com

Contact Info:
Name: Lawrence John
Email: inquiry@market.biz
Organization: Market.Biz
Address: S no. 51/14 First Floor, Office Number 4, Vishwa Arcade, Near Navale Lawns, Pune, Maharashtra, India 411041.
Phone: +1(857)2390696

Source URL: http://marketersmedia.com/u-s-uterine-fibroid-market-is-expected-to-reach-usd-39993-2-million-by-2022/212567

For more information, please visit https://market.biz/report/u-s-uterine-fibroid-market-mrf/102064/

Source: MarketersMedia

Release ID: 212567